C. Lucchinetti et al., A quantitative analysis of oligodendrocytes in multiple sclerosis lesions - A study of 113 cases, BRAIN, 122, 1999, pp. 2279-2295
We studied quantitatively the fate of oligodendrocytes (OGs) during lesion
formation in 395 lesion areas from biopsy and autopsy tissue of 113 multipl
e sclerosis cases. The density of OGs in multiple sclerosis lesions was var
iable at all stages of demyelinating activity, ranging from nearly complete
loss to values exceeding those in the periplaque white matter (range 0-970
OGs/mm(2)). To determine whether there were distinct patterns of OG pathol
ogy in different patients, we restricted our analysis to the 56 cases in wh
ich the longitudinal extent of the lesion extended from periplaque white ma
tter into the active demyelinating edge and inactive plaque centre, Two maj
or groups of OG pathology were defined by the presence or absence of increa
sed OGs within the lesion, In 70% (39 out of 56) of the cases, OGs were var
iably reduced during active stages of myelin destruction, but reappeared wi
thin inactive or remyelinating areas. In inactive, areas, an increased numb
er of OGs expressing proteolipid protein (PLP) mRNA compared with those exp
ressing myelin oligodendrocyte glycoprotein (MOG) suggested these cells may
have been derived from the progenitor pool In the remaining 30% (17 out of
56) of the cases, extensive destruction of myelinating cells at active sit
es of demyelination was observed, but OGs were absent in inactive plaque ar
eas without remyelination, In all lesions from a given patient the pattern
of OG pathology remained consistent, A highly significant negative correlat
ion was observed between number of macrophages in lesions and number of MOG
- and PLP mRNA-labelled OGs (MOG: p = -0,32, P < 0.0000118; PLP mRNA: r = -
0,23, P < 0,00238), OG density did not correlate with T-cell and plasma cel
l inflammation, or axonal loss. The profound heterogeneity in extent and to
pography of OG destruction in active demyelinating lesions suggests that in
subsets of multiple sclerosis patients, myelin, mature OGs and possibly OG
progenitors are differentially affected.